Compare 10X Genomics Inc (TXG) vs Wipro Limited (WIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Wipro Limited — how do they compare? 10X Genomics Inc trades at $47.2 (market cap $5.48B), while Wipro Limited trades at $1.83 (market cap $18.49B). The key difference: Wipro Limited is far larger — about 3.4× 10X Genomics Inc's market cap, and Wipro Limited pays a 4.68% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | WIT | |
|---|---|---|
Market Cap | $5.48B | $18.49B |
Sector | Health | Technology |
52-Week High | $45.80 | $3.06 |
52-Week Low | $11.34 | $1.82 |
Enterprise Value | $5.02B | $16.42B |
Dividend Yield | — | 4.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Wipro Limited
Wipro is a leading global IT services provider, with 175,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive over half of its revenue (57%) from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.
Read more on WIT →
